Comparison of Two D-Dimers Dosing Techniques

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3027 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study of the possibility of substitution of the automated STAGO D-Dimers method with the semi-automated VIDAS method, which is more expensive, longer to implement and requires the use of a dedicated automaton.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs

NCT03868956

Deep Vein Thrombosis

COMPLETED NA

Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs

NCT03634124

Deep Vein Thrombosis Total Hip Prosthesis Knee Prosthesis

COMPLETED PHASE3

The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study

NCT02038530

Suspected Deep Vein Thrombosis

COMPLETED

Prediction of Thrombosis Using D-dimer Trends in COVID-19

NCT04827160

Covid19

COMPLETED

Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis

NCT02078154

Deep Venous Thrombosis

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To compare D-Dimer assay techniques in the exclusion of VTE (Thromboembolic Venous Disease):• BIOMERIEUX: D-Dimers VIDAS (considered as reference technique)• STAGO: D-Di PlusOn a population of patients recruited in Brest for a period of 1 year: patients for whom a dosage of VIDAS D-dimers is prescribed (approximately 3700 patients)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Coagulation Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

D-Dimers patients

population recruited in Brest for a period of 1 year: patients for whom a dose of VIDAS D-dimers is prescribed (approximately 3700 patients)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients for whom a dosage of D-Dimers VIDAS is prescribed in the context of a suspicion of VTE at Brest CHRU.
* No opposition formulated.

Exclusion Criteria

* Curative dose anticoagulant treatment whatever the indication,
* Pregnancy in progress,
* Follow-up at 3 months not possible,
* Patient refusing to participate

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes